aCenter for Health Equity, Research and Promotion (CHERP), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA;

bDepartment of Family Medicine and Community Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA;

cCenter for Public Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;

dLeonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, PA; and

eDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Correspondence to: Shimrit Keddem, PhD, MPH, Center for Health Equity Research & Promotion (CHERP), Corporal Michael J. Crescenz Veterans Affairs Medical Center, 4100 Chester Ave, Suite 203, Philadelphia, PA 19104 (e-mail: [email protected]).

Research reported in this publication was supported by the National Institute on Drug Abuse through a pilot grant from the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH: P30DA040500). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

AHRQ National Research Service Award (NRSA) Trainees Research Conference. Virtual Podium Presentation. April 13, 2023.

The authors have no funding or conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).